Patents Examined by Blessing M. Fubara
  • Patent number: 10463041
    Abstract: Stable, solid triamine compositions are disclosed. The pressed, cast, extruded or other solid compositions are suitable for antimicrobial, sanitizing and disinfectant applications. Ready-to-use solutions are obtained by dissolving the solid triamine compositions with water and the methods of use thereof are particularly suitable for cleaning, disinfecting, sanitizing, rinsing and/or lubricating. Beneficially, the solid triamine compositions are at least partially neutralized, allowing activity of 90% and greater of the biocidal triamine, and provide at least substantially similar or superior performance and micro efficacy to liquid formulations.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: November 5, 2019
    Assignee: Ecolab USA Inc.
    Inventors: Erik C. Olson, Carter M. Silvernail, Gregory G. Griese
  • Patent number: 10463047
    Abstract: The invention concerns a polymeric antimicrobial composition, a method of producing the same and the uses thereof. The ionomer composition comprises an amine functional polymer compound reacted with silver halide, optionally together with a stabilizing component, such as an organic substance carrying a sulfonamide functional group. The ionomer composition can be obtained by reacting together (i) at least one polyamine and silver halide and optionally at least one organic stabilizer substance or; (ii) at least one polyamine, at least one non-halide silver salt or silver complex, hydrogen halide and/or alkaline metal halide salt and optionally at least one organic stabilizer substance. The present ionomer composition is suitable for use as an antimicrobial coating, antimicrobial finish, antimicrobial additive and as antimicrobial component for formation of new antimicrobial materials.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: November 5, 2019
    Assignee: Argenlab Global Ltd
    Inventors: Markus Mäki, Jyri Nieminen, Harri Laaksonen, Sami Areva
  • Patent number: 10441514
    Abstract: A process for creating cold emulsions for cosmetic use involves creating a gel component by exfoliating silicate compounds with catalysts and organic materials under pressure and mixing the resulting components with water, mixing an oil phase with additional powdered components as desired, and mixing the gel component with the oil phase in a high shear mixer until a Pickering emulsion is created. The resulting emulsion is simple to manufacture, stable for long periods of time, and has a desirable texture for cosmetic use.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: October 15, 2019
    Assignee: Arclay Natural Technologies Inc.
    Inventors: Sophie Rochette, Stephan Doyon, Maria Elkurdi
  • Patent number: 10440950
    Abstract: Methods of making triamine solids are disclosed. Solids including free-flowing powders, to pressed, cast, extruded or other solids are disclosed. Compositions employing the solid triamines are provided and methods of use thereof are particularly suitable for cleaning, disinfecting, sanitizing, rinsing and/or lubricating are disclosed.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: October 15, 2019
    Assignee: Ecolab USA Inc.
    Inventors: Erik C. Olson, Carter M. Silvernail, Gregory G. Griese
  • Patent number: 10434043
    Abstract: The present invention provides a water-in-oil emulsion solid cosmetic that is further improved in terms of an excellent feeling in use (good spreadability and fresh feeling (texture)) obtained by incorporating a powder in a water phase, and that also has sufficient covering ability, stability even at high temperature, and long-lasting property. The present invention provides a water-in-oil emulsion solid cosmetic comprising an external oil phase comprising a liquid oil thickened or solidified with (A) wax and (B) disteardimonium hectorite, and an internal water phase comprising (C) an internal phase powder dispersed in an aqueous medium.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: October 8, 2019
    Inventors: Shoji Tajima, Tomoko Ikeda
  • Patent number: 10421726
    Abstract: Provided are certain pharmaceutical formulations of omecamtiv mecarbil and methods for their preparation and use.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: September 24, 2019
    Assignee: AMGEN INC.
    Inventors: Mingda Bi, Robert Kuehl
  • Patent number: 10398726
    Abstract: A template-free method of preparing zeolites from biomass can include using rice husk ash waste material as a precursor material. The zeolites can include ZSM-5 zeolites, such as, hierarchical pure zeolites and metal-loaded (Cu, Ni) ZSM-5 zeolites. This method allows for production of zeolites in a low cost and environmentally friendly manner. These ZSM-5 zeolites may be used for numerous applications, including killing cancer cells. The cancer cells may be human lung cancer cells.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: September 3, 2019
    Assignee: King Saud University
    Inventors: Jothi Ramalingam, Jesu Doss, Judith Vijaya, Hamad Al-Lohedan
  • Patent number: 10398639
    Abstract: A skin adhesive sheet is disclosed which is good in tackiness to the skin surface, does not easily dry even when used for a long time, can maintain flexibility, and is small in the shape variation. The skin adhesive sheet includes a copolymer containing the following components A and C as polymerization components, and having a water content less than 10% by mass: component A: a polysiloxane macromonomer having a plurality of polymerizable functional groups per molecule, and having a number average molecular weight of 6,000 or more; and component C: a polymerizable monomer having an alkyl group and having no fluoroalkyl group.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: September 3, 2019
    Assignee: Toray Industries, Inc.
    Inventors: Rumiko Kitagawa, Masataka Nakamura
  • Patent number: 10385165
    Abstract: The invention is directed to multi-functional N-maleimidyl polymer derivatives comprising a water soluble and non-peptidic polymer backbone having a terminal carbon, such as a poly(alkylene glycol), the terminal carbon of the polymer backbone being directly bonded to the nitrogen atom of a N-maleimidyl moiety without a linking group therebetween. The invention also provides two methods of preparing such linkerless N-maleimidyl polymer derivatives.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: August 20, 2019
    Assignee: Nektar Therapeutics
    Inventor: Xiaoming Shen
  • Patent number: 10376590
    Abstract: The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating to delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become a solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite or a prodrug thereof.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: August 13, 2019
    Inventors: Eric Dadey, Qi Li, Christopher Lindemann
  • Patent number: 10375957
    Abstract: The subject invention provides fluid formulations for use in controlling a population of a pest once it has been detected. Specifically, the subject invention pertains to a fluid bait formulation comprising a feed medium impregnated with at least one active ingredient and a liquid carrier. The invention is based on the concept of providing a unique fluid bait formulation that can be injected into a termite infestation site, where an effective amount of AI(s) is presented to the termite population, even following dehydration of the formulation, to control the termite population.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: August 13, 2019
    Inventor: Nan-Yao Su
  • Patent number: 10376541
    Abstract: There are disclosed topical silver(II) antibiotic formulations. Other embodiments are also disclosed.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: August 13, 2019
    Inventors: Perry Antelman, Bharat Madhavan, Shalom Lampert
  • Patent number: 10369101
    Abstract: The present application provides parenteral compositions of diclofenac or its pharmaceutically acceptable salt and methods for making and using such compositions. Some of the compositions of the present application has one or more following properties: (1) ready to be injectable, (2) in the form of an oil-in-water emulsion, (3) stable under appropriate storage conditions, (4) containing therapeutically effective amount of diclofenac or its pharmaceutically acceptable salt, (5) sterilizable by filtration (6) containing components acceptable by regulatory agencies (e.g. the FDA), (7) containing low oil content and thus not exacerbating hyerlipidemia, and (8) is neither hyperallergenic nor vein irritating.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: August 6, 2019
    Inventors: Franklin Okumu, Andrew X. Chen, Hailiang Chen
  • Patent number: 10363210
    Abstract: Described herein are oral care compositions comprising a crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide, together with particular co-polymers as additional excipients; including some embodiments which further comprise a calcium abrasive.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: July 30, 2019
    Assignee: Colgate-Palmolive Company
    Inventors: Suman Chopra, Dennis Ontumi, Prakasarao Mandadi, Venda Porter Maloney
  • Patent number: 10363222
    Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: July 30, 2019
    Assignee: JDS Therapeutics, LLC
    Inventor: James R Komorowski
  • Patent number: 10357034
    Abstract: The present invention relates to a cleaning liquid, in particular a cleaning liquid for cleaning surfaces and/or for sanitizing water.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: July 23, 2019
    Inventor: Robert Scoones
  • Patent number: 10357529
    Abstract: Compositions and methods for treating and/or preventing hangover are disclosed. In certain embodiments, the compositions include at least one B vitamin, activated charcoal, magnesium, and at least one herbal extract.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: July 23, 2019
    Assignee: RVRS, LLC
    Inventor: Nader George Mikhail
  • Patent number: 10350214
    Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: July 16, 2019
    Inventors: Takashi Tomimatsu, Kensuke Okazaki, Yumi Ogawa, Takahiro Yamamura
  • Patent number: 10328089
    Abstract: Disclosed are compounds of Formula 1, stereoisomers thereof and pharmaceutically acceptable salts of the compounds and stereoisomers, wherein R1 and R2 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: June 25, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zacharia Cheruvallath, John David Lawson, Christopher McBride
  • Patent number: 10328023
    Abstract: The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of: a first component including a gummy composition; a second component that is a particulate material or is a pre-formed solid unit or plurality of pre-formed solid units; and an active ingredient. The second component can be, for example, in the form of a pharmaceutically acceptable oral dosage unit, such as a tablet, a caplet, a soft shell capsule, a hard shell capsule, a microcapsule, or a pastille.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: June 25, 2019
    Assignee: Church & Dwight Co., Inc.
    Inventors: Ovidiu Romanoschi, Caryn Oryniak, Luis C. Muniz, Hiep Huatan, Nazim Kanji, Huw Jones, Lindsey Bagley, Graham Godfrey